AUZAR SURGICAL LTD

Company number 14673133 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

AUZAR SURGICAL LTD - Analysis Report

Company Number: 14673133

Analysis Date: 2025-07-29 13:44 UTC

Financial Health Assessment Report for Auzar Surgical Ltd


1. Financial Health Score: D

Explanation:
Auzar Surgical Ltd exhibits symptoms of financial distress with persistent net current liabilities and negative shareholders' funds over the last two reported periods. The company's liquidity position is weak, with current liabilities significantly exceeding current assets, and net assets are negative, indicating an overall deficit in financial resources. While the company is still active and compliant with filing deadlines, its financial "vital signs" suggest it is in a fragile state and needs remedial action to avoid worsening conditions.


2. Key Vital Signs

Metric 2025 (£) 2024 (£) Interpretation
Current Assets 3,062 8,084 Deteriorating liquidity; cash has dropped sharply.
Cash at Bank 2,562 7,584 Cash burn evident; cash reserves shrinking rapidly.
Debtors 500 500 Stable but low debtor balance; limited receivables.
Current Liabilities 11,454 11,420 Relatively stable but high short-term obligations.
Net Current Assets (Working Capital) -8,392 -3,336 Negative working capital; indicates liquidity strain.
Net Assets (Equity) -8,392 -3,336 Negative net worth; liabilities exceed assets.
Shareholders’ Funds -8,492 -3,436 Shareholder deficit; accumulated losses impacting equity.

Interpretation in Medical Analogy:
The company’s "cash flow pulse" is weak, showing signs of "circulatory distress" from rapid depletion of cash resources. The "liquidity arteries" are clogged with liabilities exceeding assets, causing a "deficit shock." The negative equity signals a "chronic illness" of accumulated losses undermining financial stability.


3. Diagnosis: Financial Condition

Auzar Surgical Ltd is currently in an unhealthy financial condition characterized by:

  • Negative Working Capital: Current liabilities more than triple current assets in the latest period, indicating difficulty meeting short-term obligations.
  • Declining Cash Reserves: Cash holding dropped by approximately two-thirds in one year, suggesting high operational cash burn or repayment of liabilities without replenishment.
  • Negative Shareholders’ Equity: Persistent losses or capital erosion have resulted in shareholder funds falling below zero, a serious warning sign.
  • No Employees: The company reported zero employees, which may indicate minimal operational activity or reliance on directors/contractors.
  • Loans from Directors: A significant portion of liabilities is owed to directors (£11,000), implying dependence on related-party financing to sustain operations.

While the company remains compliant with statutory filing requirements and is not in liquidation, these financial "symptoms" highlight an urgent need for intervention to avoid insolvency risk.


4. Recommendations

To improve financial wellness and stabilize the company’s financial health, the following actions are advised:

  1. Improve Liquidity Management:

    • Enhance cash flow forecasting and control to prevent further depletion of cash reserves.
    • Delay or restructure payment terms with creditors where possible to ease short-term pressure.
  2. Capital Injection or Debt Restructuring:

    • Consider additional equity investment from shareholders or third parties to restore positive net assets.
    • Negotiate with directors and other creditors to convert loans into equity or extend repayment terms.
  3. Cost Control and Revenue Generation:

    • Review operational costs critically to reduce cash burn, especially given no employees currently on payroll.
    • Develop or accelerate sales and contracts to improve cash inflows and reduce debtor days.
  4. Financial Monitoring and Reporting:

    • Implement regular financial health checks to monitor key metrics like cash, working capital, and liabilities.
    • Seek professional advice on restructuring or turnaround strategies if cash flow remains constrained.
  5. Strategic Review:

    • Assess market position and business model viability in the manufacture of medical instruments sector.
    • Explore partnerships or diversification to increase resilience.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.